Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Green Growth Group Inc.
Greenhouse Naturals LLC
Common stock
Common stock
Green Growth Group Inc.
Common stock
Greenhouse Naturals LLC
Common stock subscribed but not issued
Additional paid-in capital
Additional paid-in capital
Green Growth Group Inc.
Additional paid-in capital
Greenhouse Naturals LLC
Accumulated deficit
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2020       314,418,812     11,413          
Beginning balance at Dec. 31, 2020 $ 8,100     $ 314     $ 5 $ 112,975     $ (104,617) $ (577)
Issuance of subscribed shares (in shares)       11,413     (11,413)          
Issuance of subscribed shares 0           $ (5) 5        
Stock grants (in shares)       256,591                
Release of shares under stock grants 235             235        
Exercise of stock options (in shares)       277,373                
Exercise of stock options 38             38        
Exercise of warrants (in shares)       980,062                
Exercise of warrants 93     $ 1       92        
Amortization of option grants 12,494             12,494        
Issuance of stand-alone warrants 832             832        
Issuance of warrants with stock 655             655        
Conversion of debentures payable (in shares)       4,610,645                
Conversion of debentures payable to equity 1,357     $ 5       1,352        
Conversion of promissory notes (in shares)       11,399,268                
Conversion of promissory notes to equity 3,821     $ 11       3,810        
Common stock issued to settle obligations (in shares)       71,691                
Common stock issued to settle obligations 54             54        
Common stock issued to purchase property and equipment (in shares)       750,000                
Common stock issued to purchase property and equipment 705     $ 1       704        
Fees paid with stock (in shares)       1,234,308                
Fees paid with stock 1,108     $ 2       1,106        
Common stock returned to the Company (in shares)       (79,815)                
Common stock returned to the Company (10)             (10)        
Equity issuance costs (387)             (387)        
Common stock issued as purchase consideration (in shares)       100,000                
Purchase of minority interests in certain of the Company's subsidiaries (10)             965       (975)
Distributions to noncontrolling interests (410)                     (410)
Net income 7,624                   7,225 399
Ending balance (in shares) at Dec. 31, 2021       334,030,348     0          
Ending balance at Dec. 31, 2021 36,299     $ 334     $ 0 134,920     (97,392) (1,563)
Issuance of subscribed shares (in shares)       70,000                
Issuance of subscribed shares 39                      
Stock grants (in shares)       402,203                
Release of shares under stock grants $ 0                      
Exercise of stock options (in shares) 367,248     55,000                
Exercise of stock options $ 10             10        
Cashless exercise of stock options (in shares)       200,000                
Cashless exercise of warrants       317,298                
Forfeiture of restricted shares (in shares)       (32,609)                
Conversion of promissory notes (in shares)       1,142,858                
Conversion of promissory notes to equity 400     $ 1       399        
Common stock issued to settle obligations (in shares)       375,000                
Common stock issued to settle obligations 275             275        
Common stock issued under licensing agreement (in shares)       218,345                
Common stock issued under licensing agreement 121             121        
Common stock issued to purchase property and equipment (in shares)       422,535                
Common stock issued to purchase property and equipment 300     $ 1       299        
Common stock issued as purchase consideration (in shares)         2,343,750 2,000,000            
Common stock issued as purchase consideration   $ 1,500 $ 712   $ 3 $ 2     $ 1,497 $ 710    
Purchase of minority interests in certain of the Company's subsidiaries (2,000)             (2,165)       165
Distributions to noncontrolling interests (259)                     (259)
Stock-based compensation (in shares)             70,000          
Stock-based compensation 6,338           $ 39 6,299        
Net income 13,614                   13,468 146
Ending balance (in shares) at Dec. 31, 2022       341,474,728     70,000          
Ending balance at Dec. 31, 2022 $ 57,310     $ 341     $ 39 $ 142,365     $ (83,924) $ (1,511)